Balance Sheet
Cash Flow Statement
Cash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmatrix (PULM) Gains from Investment Securities (2016 - 2025)

Pulmatrix's Gains from Investment Securities history spans 12 years, with the latest figure at -$54000.0 for Q3 2025.

  • For Q3 2025, Gains from Investment Securities fell 38.46% year-over-year to -$54000.0; the TTM value through Dec 2025 reached -$67000.0, down 200.0%, while the annual FY2025 figure was -$67000.0, 296.79% down from the prior year.
  • Gains from Investment Securities for Q3 2025 was -$54000.0 at Pulmatrix, down from -$13000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $9.0 million in Q3 2023 and bottomed at -$9.3 million in Q4 2023.
  • The 5-year median for Gains from Investment Securities is $60000.0 (2022), against an average of $155950.0.
  • The largest YoY upside for Gains from Investment Securities was 14865.0% in 2023 against a maximum downside of 23825.64% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $196006.0 in 2021, then crashed by 119.9% to -$39000.0 in 2022, then tumbled by 23825.64% to -$9.3 million in 2023, then soared by 102.03% to $189000.0 in 2024, then crashed by 128.57% to -$54000.0 in 2025.
  • Per Business Quant, the three most recent readings for PULM's Gains from Investment Securities are -$54000.0 (Q3 2025), -$13000.0 (Q1 2025), and $189000.0 (Q4 2024).